Cite
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
MLA
Suzan M Hammond, et al. “Delivery of Oligonucleotide‐based Therapeutics: Challenges and Opportunities.” EMBO Molecular Medicine, vol. 13, no. 4, Apr. 2021. EBSCOhost, https://doi.org/10.15252/emmm.202013243.
APA
Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, … Virginia Arechavala‐Gomeza. (2021). Delivery of oligonucleotide‐based therapeutics: challenges and opportunities. EMBO Molecular Medicine, 13(4). https://doi.org/10.15252/emmm.202013243
Chicago
Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, et al. 2021. “Delivery of Oligonucleotide‐based Therapeutics: Challenges and Opportunities.” EMBO Molecular Medicine 13 (4). doi:10.15252/emmm.202013243.